Durect corporation reports third quarter 2023 financial results and business update

- webcast of earnings call today, november 13th at 4:30 p.m. et - topline data from ahfirm trial showed compelling efficacy signal in favor of larsucosterol in the key secondary endpoint of mortality at 90 days cupertino, calif.

DRRX Ratings Summary

DRRX Quant Ranking